Citadel Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$272K Sell
79,500
-95,300
-55% -$321K ﹤0.01% 10694
2025
Q4
$495K Buy
174,800
+11,200
+7% +$57.8K ﹤0.01% 9043
2025
Q3
$1.14M Buy
163,600
+79,500
+95% +$561K ﹤0.01% 7253
2025
Q2
$498K Sell
84,100
-140,600
-63% -$809K ﹤0.01% 8646
2025
Q1
$1.44M Sell
224,700
-84,500
-27% -$815K ﹤0.01% 6176
2024
Q4
$3.67M Buy
309,200
+138,000
+81% +$2.35M ﹤0.01% 4485
2024
Q3
$4.74M Buy
171,200
+6,300
+4% +$158K ﹤0.01% 4022
2024
Q2
$3.93M Buy
164,900
+87,100
+112% +$2.04M ﹤0.01% 4127
2024
Q1
$1.37M Buy
77,800
+2,300
+3% +$33.9K ﹤0.01% 6273
2023
Q4
$1.19M Buy
75,500
+30,900
+69% +$319K ﹤0.01% 6342
2023
Q3
$384K Sell
44,600
-8,200
-16% -$58.3K ﹤0.01% 8647
2023
Q2
$417K Sell
52,800
-6,600
-11% -$45.9K ﹤0.01% 8334
2023
Q1
$443K Buy
59,400
+9,700
+20% +$96.4K ﹤0.01% 8560
2022
Q4
$586K Sell
49,700
-15,200
-23% -$174K ﹤0.01% 7911
2022
Q3
$598K Sell
64,900
-9,300
-13% -$113K ﹤0.01% 8067
2022
Q2
$733K Buy
74,200
+4,000
+6% +$80.7K ﹤0.01% 7748
2022
Q1
$2.42M Buy
70,200
+18,200
+35% +$591K ﹤0.01% 5675
2021
Q4
$2.59M Sell
52,000
-158,900
-75% -$8.37M ﹤0.01% 5635
2021
Q3
$9.7M Buy
210,900
+2,000
+1% +$79.3K ﹤0.01% 3134
2021
Q2
$6.25M Buy
208,900
+24,400
+13% +$498K ﹤0.01% 3968
2021
Q1
$3.75M Buy
+184,500
New +$3.89M ﹤0.01% 4916

Other funds holding ASPN

Citadel Advisors's ASPN Position: Q1 2026 in Review

Citadel Advisors reduced its Aspen Aerogels (ASPN) stake by 33% in Q1 2026, selling an estimated $961K and leaving 581,187 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #6076.

Citadel Advisors first reported a position in ASPN in Q4 2015 and has held it in 25 quarters since. The position peaked at $15M in Q2 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Citadel Advisors held 581,187 shares of Aspen Aerogels worth $1.99M as of Q1 2026.
  • Citadel Advisors sold 285,031 Aspen Aerogels shares in Q1 2026, an estimated $961K.
  • Aspen Aerogels made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6076 holding.
  • Citadel Advisors first reported a position in Aspen Aerogels in Q4 2015 and has held it in 25 quarters since.
  • Citadel Advisors's Aspen Aerogels position peaked at $15M in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.